ArticleAging and disease2025
Association between Visual, Hearing and Dual Sensory Impairment and the Frailty Syndrome.
Article in Aging and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sensory loss has been associated with multiple adverse health conditions. However, the combined effect of visual and hearing impairment on frailty is unknown. The aim of this study was to examine the association between visual, hearing, and dual-sensory impairment and frailty prevalence. This cross-sectional study investigated 105,406 participants aged ≥39 years from the UK Biobank study. Visual acuity was measured with a chart, as the logarithm of the minimum angle of resolution (LogMAR); functional auditory capacity was measured with a digit triplet test, as the speech reception threshold in noise (SRTn). Dual sensory impairment was defined as the presence of both visual impairment (LogMAR > 0.3 units) and hearing impairment (SRTn ≥ -5.5 dB SNR). To define the frailty syndrome, two methods were used, the frailty phenotype and the FRAIL scale. Analyses were conducted using logistic models adjusted for relevant confounders. Among the participants, 54.3% were women, with a mean age of 56.8 years (SD: 8.1, range 39 to 72). The prevalence of frailty was 3.5%, defined with the frailty phenotype, and 3.6%, using the FRAIL scale. For visual impairment, the OR (95% CI) of frailty was 1.51 (1.28-1.79) for the frailty phenotype, and 1.31 (1.10-1.57), for the FRAIL scale. For hearing impairment, in comparison with having normal hearing, the OR (95% CI) associated with insufficient and poor hearing were 1.32 (1.20-1.45) and 1.83 (1.53-2.19), respectively for the frailty phenotype, and 1.32 (1.19-1.46) and 1.93 (1.60-2.33) for the FRAIL scale. Estimates for the association between dual-sensory impairment and frailty were 2.22 (1.65-2.99) for the frailty phenotype, and 1.73 (1.23-2.42) for the FRAIL scale. Visual and hearing impairments were related to frailty. Having dual-sensory impairment was associated with twice the likelihood of frailty syndrome in comparison with having none of them.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.